FULL TEST x1
x1
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCE
x1 x1
x1
x1 x1
D PRACTICE A PRACTICAL APPROACH 5TH
x1 x1 x1 x1 x1
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
x1 x1 x1 x1 x1 x
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
1 x1 x1 x1 x1 x1
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
x1 x1 x1 x1 x1 x1 x1 x1 x1
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
x1 x1 x1 x1 x1 x1 x1
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
x1 x 1 x1 x 1 x1 x 1
For more Test banks, ATI, HES! exams, and more contact us.
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
, Tableofcontent x1 x1
Chapter I Issues for the Practitioner in Drug Therapy
x1 x1 x1 x1 x1 x1 x1 x1
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
x1 x1 x1 x1 x1 x1 x1 x1
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics C
x1 x1 x 1 x1 x1 x1 x 1 x1 x1 x 1 x1 x1
hapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation C
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
hapter 5 Pharmacotherapy Principles in Older Adults
x1 x1 x1 x1 x1 x1
Chapter 6 Principles of Antimicrobial Therapy Chapt
x1 x1 x1 x1 x1 x1
er 7 Pharmacogenomies
x1 x1
Chapter 8 The Economics of Pharmacotherapeutics
x1 x1 x1 x1 x1 x1
Chapter 9 Pharmacotherapy of Pain Management
x1 x1 x1 x1 x1
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
Chapter 11 Cannabis and Pain Management
x1 x1 x1 x1 x1
Chapter 12 Contact Dermatitis x1 x1 x1
Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
Chapter 14 Psoriasis x1 x1
Chapter I5 Acne Vulgaris and Rosacea Chapt
x1 x1 x1 x1 x1 x1
er 16 Ophthalmic Disorders
x1 x1 x1
Chapter I7 Otitis Media and Otitis Externa C
x1 x1 x1 x1 x1 x1 x1
hapter I8 Hypertension x1 x1
Chapter I9 Hyperlipidemia x1 x1
Chapter 20 Chronic Stable Angina and Myocardial Infarction
x1 x1 x1 x1 x1 x1 x1 x1
Chapter 2I Heart Failure x1 x1 x1
Chapter 22 Arrhythmias x1 x1
Chapter 23 Respiratory Infections
x1 x1 x1
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Cha
x1 x1 x1 x1 x1 x1 x1 x1
pter 25 Gastric, Functional, and Inflammatory Bowel Disorders Chapt
x1 x1 x1 x1 x1 x1 x1 x1
er 26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chap
x1 x1 x1 x1 x1 x1 x1 x1 x1
ter 27 Liver Diseases
x1 x1 x1
Chapter 28 Urinary Tract Infection
x1 x1 x1 x1
Chapter 29 Prostatic Disorders and Erectile Dysfunction Chap
x1 x1 x1 x1 x1 x1 x1
ter 30 Overactive Bladder
x1 x1 x1
Chapter 3I Sexually Transmitted Infection
x1 x1 x1 x1
s Chapter 32 Osteoarthritis and Gout Cha
x1 x1 x1 x1 x1 x1
pter 33 Osteoporosis
x1 x1
Chapter 34 Rheumatoid Arthritis x1 x1 x1 x1
Chapter 35 Headaches x1 x1
Chapter 36 Seizure Disorders x1 x1 x1 x1
Chapter 37 Alzheimer's Disease x1 x1 x1 x 1
Chapter 38 Parkinson's Diseas x1 x1 x1
e
Chapter 39 Major Depressive Disorder and Bipolar Disorders
x1 x1 x1 x1 x1 x1 x1 x1
Chapter 40 Anxiety Disorders x1 x1 x1
Chapter 41 Sleep Disorders x1 x 1 x 1
Chapter 42 Attention Deficit Hyperactivity Disorder
x1 x1 x1 x1 x1 x1
Chapter 43 Substance Use Disorders
x1 x1 x1 x1
Chapter 44 Diabetes Mellitus x1 x1 x1
Chapter 45 Thyroid and Parathyroid Disorders
x1 x1 x1 x1 x1
,Chapter 46 Allergies and Allergic Reactions
x1 x1 x1 x1 x1
Chapter 47 Human Immunodeficiency Viru
x1 x1 x1 x1 x1
s Chapter 48 Organ Transplantation
x1 x1 x1 x1
Chapter 49 Thromboembolic Disorders Ch
x1 x1 x1 x1
apter 50 Anemias
x1 x1
Chapter 5l Immunizations Cha
x1 x1 x1
pter 52 Smoking Cessation Cha
x1 x1 x1 x1
pter 53 Weight Loss Chapter 5
x1 x1 x1 x1 x1
4 Contraception
x1
Chapter 55 Menopause x1 x1
Chapter 56 Vaginitis x1 x1
, x1
lOMoAR cPSD|
x1 21007614
x 1 x1
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
x1 x1 x1 x1 x1 x1 x1 x1
MULTIPLE CHOICE x1
1. Nurse practitioner prescriptive authority is regulated by:
x1 x1 x1 x1 x1 x1
A. The National Council of State Boards of Nursing
x1 x1 x1 x1 x1 x1 x1
B. The U.S. Drug Enforcement Administration
x1 x1 x1 x1
C. The State Board of Nursing for each state
x1 x1 x1 x1 x1 x1 x1
D. The State Board of Pharmacy
x1 x1 x1 x1
ANS: C x 1 PTS: x 1 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
x1 x1 x1 x1 x1 x1 x1
A. The National Council of State Boards of Nursing
x1 x1 x1 x1 x1 x1 x1
B. The U.S. Drug Enforcement Administration
x1 x1 x1 x1
C. The State Board of Nursing
x1 x1 x1 x1
D. The State Board of Medical Examiners
x1 x1 x1 x1 x1
ANS: D x 1 PTS: x 1 1
3. Clinical judgment in prescribing includes:
x1 x1 x1 x1
A. Factoring in the cost to the patient of the medication prescribed
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
B. Always prescribing the newest medication available for the disease process
x1 x1 x1 x1 x1 x1 x1 x1 x1
C. Handing out drug samples to poor patients
x1 x1 x1 x1 x1 x1
D. Prescribing all generic medications to cut costs
x1 x1 x1 x1 x1 x1
ANS: A x 1 PTS: x 1 1
4. Criteria for choosing an effective drug for a disorder include:
x1 x1 x1 x1 x1 x1 x1 x1 x1
A. Asking the patient what drug they think would work best for them
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
B. Consulting nationally recognized guidelines for disease management
x1 x1 x1 x1 x1 x1
C. Prescribing medications that are available as samples before writing a prescription
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
D. Following U.S. Drug Enforcement Administration (DEA) guidelines fo
x1 x1 x1 x1 x1 x1 x1
r prescribing
x1
ANS: B x 1 PTS: x 1 1
5. Nurse practitioner practice may thrive under health-care reform due to:
x1 x1 x1 x1 x1 x1 x1 x1 x1
A. The demonstrated ability of nurse practitioners to control costs and improve patie
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
nt outcomesx1
B. The fact that nurse practitioners will be able to practice independently
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
C. The fact that nurse practitioners will have full reimbursement under health-
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
care reform x1
D. The ability to shift accountability for Medicaid to the state level
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
ANS: A x 1 PTS: x 1 1
x1
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCE
x1 x1
x1
x1 x1
D PRACTICE A PRACTICAL APPROACH 5TH
x1 x1 x1 x1 x1
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
x1 x1 x1 x1 x1 x
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
1 x1 x1 x1 x1 x1
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
x1 x1 x1 x1 x1 x1 x1 x1 x1
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
x1 x1 x1 x1 x1 x1 x1
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
x1 x 1 x1 x 1 x1 x 1
For more Test banks, ATI, HES! exams, and more contact us.
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
, Tableofcontent x1 x1
Chapter I Issues for the Practitioner in Drug Therapy
x1 x1 x1 x1 x1 x1 x1 x1
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
x1 x1 x1 x1 x1 x1 x1 x1
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics C
x1 x1 x 1 x1 x1 x1 x 1 x1 x1 x 1 x1 x1
hapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation C
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
hapter 5 Pharmacotherapy Principles in Older Adults
x1 x1 x1 x1 x1 x1
Chapter 6 Principles of Antimicrobial Therapy Chapt
x1 x1 x1 x1 x1 x1
er 7 Pharmacogenomies
x1 x1
Chapter 8 The Economics of Pharmacotherapeutics
x1 x1 x1 x1 x1 x1
Chapter 9 Pharmacotherapy of Pain Management
x1 x1 x1 x1 x1
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
Chapter 11 Cannabis and Pain Management
x1 x1 x1 x1 x1
Chapter 12 Contact Dermatitis x1 x1 x1
Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
Chapter 14 Psoriasis x1 x1
Chapter I5 Acne Vulgaris and Rosacea Chapt
x1 x1 x1 x1 x1 x1
er 16 Ophthalmic Disorders
x1 x1 x1
Chapter I7 Otitis Media and Otitis Externa C
x1 x1 x1 x1 x1 x1 x1
hapter I8 Hypertension x1 x1
Chapter I9 Hyperlipidemia x1 x1
Chapter 20 Chronic Stable Angina and Myocardial Infarction
x1 x1 x1 x1 x1 x1 x1 x1
Chapter 2I Heart Failure x1 x1 x1
Chapter 22 Arrhythmias x1 x1
Chapter 23 Respiratory Infections
x1 x1 x1
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Cha
x1 x1 x1 x1 x1 x1 x1 x1
pter 25 Gastric, Functional, and Inflammatory Bowel Disorders Chapt
x1 x1 x1 x1 x1 x1 x1 x1
er 26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chap
x1 x1 x1 x1 x1 x1 x1 x1 x1
ter 27 Liver Diseases
x1 x1 x1
Chapter 28 Urinary Tract Infection
x1 x1 x1 x1
Chapter 29 Prostatic Disorders and Erectile Dysfunction Chap
x1 x1 x1 x1 x1 x1 x1
ter 30 Overactive Bladder
x1 x1 x1
Chapter 3I Sexually Transmitted Infection
x1 x1 x1 x1
s Chapter 32 Osteoarthritis and Gout Cha
x1 x1 x1 x1 x1 x1
pter 33 Osteoporosis
x1 x1
Chapter 34 Rheumatoid Arthritis x1 x1 x1 x1
Chapter 35 Headaches x1 x1
Chapter 36 Seizure Disorders x1 x1 x1 x1
Chapter 37 Alzheimer's Disease x1 x1 x1 x 1
Chapter 38 Parkinson's Diseas x1 x1 x1
e
Chapter 39 Major Depressive Disorder and Bipolar Disorders
x1 x1 x1 x1 x1 x1 x1 x1
Chapter 40 Anxiety Disorders x1 x1 x1
Chapter 41 Sleep Disorders x1 x 1 x 1
Chapter 42 Attention Deficit Hyperactivity Disorder
x1 x1 x1 x1 x1 x1
Chapter 43 Substance Use Disorders
x1 x1 x1 x1
Chapter 44 Diabetes Mellitus x1 x1 x1
Chapter 45 Thyroid and Parathyroid Disorders
x1 x1 x1 x1 x1
,Chapter 46 Allergies and Allergic Reactions
x1 x1 x1 x1 x1
Chapter 47 Human Immunodeficiency Viru
x1 x1 x1 x1 x1
s Chapter 48 Organ Transplantation
x1 x1 x1 x1
Chapter 49 Thromboembolic Disorders Ch
x1 x1 x1 x1
apter 50 Anemias
x1 x1
Chapter 5l Immunizations Cha
x1 x1 x1
pter 52 Smoking Cessation Cha
x1 x1 x1 x1
pter 53 Weight Loss Chapter 5
x1 x1 x1 x1 x1
4 Contraception
x1
Chapter 55 Menopause x1 x1
Chapter 56 Vaginitis x1 x1
, x1
lOMoAR cPSD|
x1 21007614
x 1 x1
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
x1 x1 x1 x1 x1 x1 x1 x1
MULTIPLE CHOICE x1
1. Nurse practitioner prescriptive authority is regulated by:
x1 x1 x1 x1 x1 x1
A. The National Council of State Boards of Nursing
x1 x1 x1 x1 x1 x1 x1
B. The U.S. Drug Enforcement Administration
x1 x1 x1 x1
C. The State Board of Nursing for each state
x1 x1 x1 x1 x1 x1 x1
D. The State Board of Pharmacy
x1 x1 x1 x1
ANS: C x 1 PTS: x 1 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
x1 x1 x1 x1 x1 x1 x1
A. The National Council of State Boards of Nursing
x1 x1 x1 x1 x1 x1 x1
B. The U.S. Drug Enforcement Administration
x1 x1 x1 x1
C. The State Board of Nursing
x1 x1 x1 x1
D. The State Board of Medical Examiners
x1 x1 x1 x1 x1
ANS: D x 1 PTS: x 1 1
3. Clinical judgment in prescribing includes:
x1 x1 x1 x1
A. Factoring in the cost to the patient of the medication prescribed
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
B. Always prescribing the newest medication available for the disease process
x1 x1 x1 x1 x1 x1 x1 x1 x1
C. Handing out drug samples to poor patients
x1 x1 x1 x1 x1 x1
D. Prescribing all generic medications to cut costs
x1 x1 x1 x1 x1 x1
ANS: A x 1 PTS: x 1 1
4. Criteria for choosing an effective drug for a disorder include:
x1 x1 x1 x1 x1 x1 x1 x1 x1
A. Asking the patient what drug they think would work best for them
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
B. Consulting nationally recognized guidelines for disease management
x1 x1 x1 x1 x1 x1
C. Prescribing medications that are available as samples before writing a prescription
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
D. Following U.S. Drug Enforcement Administration (DEA) guidelines fo
x1 x1 x1 x1 x1 x1 x1
r prescribing
x1
ANS: B x 1 PTS: x 1 1
5. Nurse practitioner practice may thrive under health-care reform due to:
x1 x1 x1 x1 x1 x1 x1 x1 x1
A. The demonstrated ability of nurse practitioners to control costs and improve patie
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
nt outcomesx1
B. The fact that nurse practitioners will be able to practice independently
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
C. The fact that nurse practitioners will have full reimbursement under health-
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
care reform x1
D. The ability to shift accountability for Medicaid to the state level
x1 x1 x1 x1 x1 x1 x1 x1 x1 x1
ANS: A x 1 PTS: x 1 1
